The certification enables Fraunhofer IZI to manufacture as well as supply the DCVax-L product for clinical trials in Germany and throughout the European Union. Fraunhofer said receiving manufacturing
IDX719 is an NS5A inhibitor that demonstrated pan-genotypic activity in a recent proof-of-concept clinical trial in genotypes 1-4, treatment-naive HCV patients. Idenix president and chief executive officer Ron
The single-center trial of aldoxorubicin, a tumor-targeting conjugate of doxorubicin, is designed to enroll up to 24 patients with advanced solid tumors who have failed other therapies. Doxorubicin
The multinational, single-arm, open-label study of JX-594 is administered weekly by intravenous infusions in sorafenib-naive patients with advanced HCC. The trial will be conducted in South Korea, US
The Levetiracetam extended-release tablets, 500mg and 750mg, are the generic equivalent of UCB’s Keppra XR. As per IMS Health, the total combined sales in the US for the
Eltrombopag, known by the brand name Promacta in the US and Revolade in the European Union and other countries, is indicated for thrombocytopenia in patients with chronic immune
TIQUAS (Targeted In-depth QUAntification of cell Signaling), Activiomics’ proprietary technology, offers insight into which proteins or pathways have been activated following a cell signaling event. The technology uses
The trial will compare Qutenza(R) (8% capsaicin patch) to pregabalin as a treatment for peripheral neuropathic pain. Pregabalin is an oral therapy used to treat peripheral neuropathic pain.
The investment will help the company become premier provider of bio-derived products and critically needed injectables, according to Blackstone. NantWorks and NantPharma chairman Patrick Soon-Shiong said NantPharm will
The Brazil funded plant will initially package, store and distribute the anti-retroviral drug, Nevirapine.produce Nevirapine, which is manufactured in Brazil. The drugs from the new plant are expected
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.